These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22369213)

  • 1. Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations.
    Cohen EM; Machado KS; Cohen M; de Souza ON
    BMC Genomics; 2011 Dec; 12 Suppl 4(Suppl 4):S7. PubMed ID: 22369213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FReDoWS: a method to automate molecular docking simulations with explicit receptor flexibility and snapshots selection.
    Machado KS; Schroeder EK; Ruiz DD; Cohen EM; de Souza ON
    BMC Genomics; 2011 Dec; 12 Suppl 4(Suppl 4):S6. PubMed ID: 22369186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
    da Costa AL; Pauli I; Dorn M; Schroeder EK; Zhan CG; de Souza ON
    J Mol Model; 2012 May; 18(5):1779-90. PubMed ID: 21833828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining flexible-receptor docking experiments to select promising protein receptor snapshots.
    Machado KS; Winck AT; Ruiz DD; de Souza ON
    BMC Genomics; 2010 Dec; 11 Suppl 5(Suppl 5):S6. PubMed ID: 21210972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA.
    Kumar V; Sobhia ME
    PLoS One; 2015; 10(12):e0144635. PubMed ID: 26658674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.
    Schroeder EK; Basso LA; Santos DS; de Souza ON
    Biophys J; 2005 Aug; 89(2):876-84. PubMed ID: 15908576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features.
    De Paris R; Quevedo CV; Ruiz DD; Norberto de Souza O
    PLoS One; 2015; 10(7):e0133172. PubMed ID: 26218832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model.
    De Paris R; Vahl Quevedo C; Ruiz DD; Gargano F; de Souza ON
    BMC Bioinformatics; 2018 Jun; 19(1):235. PubMed ID: 29929475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. wFReDoW: a cloud-based web environment to handle molecular docking simulations of a fully flexible receptor model.
    De Paris R; Frantz FA; de Souza ON; Ruiz DD
    Biomed Res Int; 2013; 2013():469363. PubMed ID: 23691504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis.
    Kruh NA; Rawat R; Ruzsicska BP; Tonge PJ
    Protein Sci; 2007 Aug; 16(8):1617-27. PubMed ID: 17600151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.
    Merget B; Sotriffer CA
    PLoS One; 2015; 10(5):e0127009. PubMed ID: 25996598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.
    Basso LA; Zheng R; Musser JM; Jacobs WR; Blanchard JS
    J Infect Dis; 1998 Sep; 178(3):769-75. PubMed ID: 9728546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.
    Pauli I; dos Santos RN; Rostirolla DC; Martinelli LK; Ducati RG; Timmers LF; Basso LA; Santos DS; Guido RV; Andricopulo AD; Norberto de Souza O
    J Chem Inf Model; 2013 Sep; 53(9):2390-401. PubMed ID: 23889525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating isoniazid resistance using molecular modeling.
    Wahab HA; Choong YS; Ibrahim P; Sadikun A; Scior T
    J Chem Inf Model; 2009 Jan; 49(1):97-107. PubMed ID: 19067649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Modulation of the Induced-Fit Conformational Change for Slow-Onset Inhibition in Mycobacterium tuberculosis InhA.
    Lai CT; Li HJ; Yu W; Shah S; Bommineni GR; Perrone V; Garcia-Diaz M; Tonge PJ; Simmerling C
    Biochemistry; 2015 Aug; 54(30):4683-91. PubMed ID: 26147157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.